// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Home-based versus hospital monitoring of respiratory function changes in Duchenne muscular dystrophy (DMD)

Thomas Meier - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Duchenne muscular dystrophy

Glucocorticoid

Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)

Vanessa Compton - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Holistic needs assessment (HNA) in lung cancer patients; bridging health and social care

Mary Mambwere - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Lung cysts in pulmonary alveolar proteinosis.

Maria Kokosi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary alveolar proteinosis

N/A

Using a rapid prioritisation process to identify health research priorities in LMICs

Andy Dickens - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry

James D. Chalmers - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Misdiagnosis of children’s asthma is common in UK primary care and can be improved with objective tests

David Lo - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Effects on CPAP use of a patient support mobile app

Heather Engleman - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Unbiased clinical cluster analysis across a combined European and a Brazilian severe asthma (SA) population.

John Riley - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Systems approach to improving safety with intercostal chest drains (ICD)

Burhan Khan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Snoring and nocturnal gastroesophageal reflux in the ECRHS III: Association to lung function and respiratory symptoms

ssur Ingi Emilsson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial

Martin Kolb - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Nintedanib

Exercise may improve airway clearance and alleviate hyperinflation in children with Cystic Fibrosis

Kate Regan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

A systematic review of comorbidities and outcomes of patients with pleural infection

Tamsin Cargill - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Using digital and social media to highlight the risks of occupational exposures as a cause of lung diseases

Emma Thompson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Robustness of assessment of pulmonary endpoints in phase 3 trials with ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients with chronic Pseudomonas aeruginosa (PA) infections

Anne O'Donnell - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

ARD-3150

Epidemiology of silicosis reported to the SWORD scheme in the UK

Christopher Barber - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prulifloxacin

Exploring supported self-management practices of healthcare professionals for South Asian patients with asthma

Salina Ahmed - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Study to assess the need for CT abdomen/pelvis in patients with unprovoked pulmonary embolism

Arushi Sharma - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary embolism

N/A

Characterising the Adult Obese-Difficult Asthma Phenotype within the WATCH cohort

Anna Freeman - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved